Introduction

Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease

Volumn , Issue , 2006, Pages 1-26

  Pollard, K Michael ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoantibodies; Autoantibodies as diagnostic markers; Autoantibodies as molecular and cellular probes; Autoantibodies in experimental models of autoimmunity; Autoimmunity

Indexed keywords

EID: 84889767814     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527607854.ch1     Document Type: Chapter

References (80)

1. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298-300.
2. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301-305.
3. Theofilopoulos, A. N., and D.H. Kono. 2002. A genetic analysis of lupus. Allergy 57 Suppl 72:67-74.
4. Croker, B. P., G. Gilkeson, and L. Morel. 2003. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun 4:575-585.
5. Morel, L., X.H. Tian, B. P. Croker, and E. K. Wakeland. 1999. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11:131-139.
6. Marrack, P., J. Kappler, and B. L. Kotzin. 2001. Autoimmune disease: why and where it occurs. Nat Med 7:899-905.
7. Rubin, R. L. 1999. Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol 11:357-363.
8. Rubin, R. L., S. A. Bell, and R.W. Burlingame. 1992. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest 90:165-173.
9. Burlingame, R.W., and R. L. Rubin. 1991. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest 88:680-690.
10. Pollard, K. M., and P. Hultman. 1997. Effects of mercury on the immune system. Met Ions Biol Syst 34:421-440.
11. Takeuchi, K., S. J. Turley, E.M. Tan, and K.M. Pollard. 1995. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J Immunol 154:961-971.
12. Yang, J. M., S. J. Baserga, S. J. Turley, and K.M. Pollard. 2001. Fibrillarin and other snoRNP proteins are targets of autoantibodies in xenobiotic-induced autoimmunity. Clin Immunol 101:38-50.
13. Jiang, X., G. Khursigara, and R. L. Rubin. 1994. Transformation of lupusinducing drugs to cytotoxic products by activated neutrophils. Science 266:810-813.
14. Kretz-Rommel, A., and R. L. Rubin. 1997. A metabolite of the lupus-inducing drug procainamide prevents anergy induction in T cell clones. J Immunol 158:4465-4470.
15. Kretz-Rommel, A., S. R. Duncan, and R. L. Rubin. 1997. Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. J Clin Invest 99:1888-1896.
16. Kretz-Rommel, A., and R. L. Rubin. 2000. Disruption of positive selection of thymocytes causes autoimmunity. Nat Med 6:298-305.
17. Goodnow, C.C. 1992. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 10:489-518.
18. Radic, M.Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 12:487-520.
19. Rosen, A., L. Casciola-Rosen, and J. Ahearn. 1995. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 181:1557-1561.
20. Navratil, J. S., J.M. Sabatine, and J.M. Ahearn. 2004. Apoptosis and immune responses to self. Rheum Dis Clin North Am 30:193-212.
21. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R.M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196:1091-1097.
22. Steinman, R. M., S. Turley, I. Mellman, and K. Inaba. 2000. The induction of tolerance by dendritic cells that have cap tured apoptotic cells. J Exp Med 191:411-416.
23. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5:1249-1255.
24. Huynh, M.L., V. A. Fadok, and P.M. Henson. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109:41-50.
25. Reiter, I., B. Krammer, and G. Schwamberger. 1999. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol 163:1730-1732.
26. Pollard, K. M., D.L. Pearson, M. Bluthner, and E.M. Tan. 2000. Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J Immunol 165:2263-2270.
27. Shlomchik, M. J., J. E. Craft, and M.J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1:147-153.
28. Baxter, A. G., and P. D. Hodgkin. 2002. Activation rules: the two-signal theories of immune activation. Nat Rev Immunol 2:439-446.
29. Yang, J. M., B. Hildebrandt, C. Luderschmidt, and K.M. Pollard. 2003. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Arthritis Rheum 48:210-217.
30. Lang, B., and A. Vincent. 2003. Autoantibodies to ion channels at the neuromuscular junction. Autoimmun Rev 2:94-100.
31. Kohn, L. D., and N. Harii. 2003. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance. Autoimmunity 36:331-337.
32. Liu, Z., and L. A. Diaz. 2001. Bullous pemphigoid: end of the century overview. J Dermatol 28:647-650.
33. Giorgio Natali, P., and E.M. Tan. 1972. Experimental renal disease induced by DNA-anti-DNA immune complexes. J Clin Invest 51:345-355.
34. Tan, E. M., P.H. Schur, R. I. Carr, and H.G. Kunkel. 1966. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45:1732-1740.
35. Tan, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151.
36. Tan, E. M., E. K. Chan, K. F. Sullivan, and R. L. Rubin. 1988. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121-141.
37. Burlingame, R.W. 1997. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus. Clin Lab Med 17:367-378.
38. Burlingame, R.W., M.L. Boey, G. Starkebaum, and R. L. Rubin. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:184-192.
39. Pollard, K. M., G. Reimer, and E.M. Tan. 1989. Autoantibodies in scleroderma. Clin Exp Rheumatol 7 Suppl 3:S57-62
40. von Muhlen, C. A., and E.M. Tan. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323-358.
41. Reimer, G., V. D. Steen, C. A. Penning, T. A. Medsger, Jr., and E.M. Tan. 1988. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31:525-532.
42. Gall, J. G. 2000. Cajal bodies: the first 100 years. Annu Rev Cell Dev Biol 16:273-300.
43. Raska, I., R. L. Ochs, L. E. Andrade, E. K. Chan, R. Burlingame, C. Peebles, D. Gruol, and E.M. Tan. 1990. Association between the nucleolus and the coiled body. J Struct Biol 104:120-127.
44. Takasaki, Y., J.S. Deng, and E.M. Tan. 1981. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154:1899-1909.
45. Moroi, Y., C. Peebles, M.J. Fritzler, J. Steigerwald, and E.M. Tan. 1980. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77:1627-1631.
46. Turley, S. J., E.M. Tan, and K.M. Pollard. 1993. Molecular cloning and sequence analysis of U3 snoRNA-associated mouse fibrillarin. Biochim Biophys Acta 1216:119-122.
47. Pollard, K. M., E. K. Chan, B. J. Grant, K. F. Sullivan, E.M. Tan, and C. A. Glass. 1990. In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol Cell Biol 10:2164-2175.
48. Chan, E. K., K. F. Sullivan, R. I. Fox, and E.M. Tan. 1989. Sjogren's syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes. J Autoimmun 2:321-327.
49. Desbos, A., P. Gonzalo, J. C. Monier, J. Tebib, J. P. Reboud, H. Perrier, J. Bienvenu, and N. Fabien. 2002. Autoantibodies directed against ribosomal proteins in systemic lupus erythematosus and rheumatoid arthritis: a comparative study. Autoimmunity 35:427-434.
50. Tan, E. M., and H.G. Kunkel. 1966. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96:464-471.
51. Lerner, M. R., J. A. Boyle, J. A. Hardin, and J. A. Steitz. 1981. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211:400-402.
52. Padgett, R. A., S.M. Mount, J. A. Steitz, and P. A. Sharp. 1983. Splicing of messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotein. Cell 35:101-107.
53. Tan, E. M., Y. Muro, and K.M. Pollard. 1994. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin Exp Rheumatol 12 Suppl 11:S27-31.
54. Pollard, K. M., J. E. Jones, E.M. Tan, A. N. Theofilopoulos, F. J. Dixon, and R. L. Rubin. 1986. Polynucleotide specificities of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol 40:197-208.
55. Reimer, G., K.M. Pollard, C. A. Penning, R. L. Ochs, M.A. Lischwe, H. Busch, and E.M. Tan. 1987. Monoclonal autoantibody from a (New Zealand black x New Zealand white) F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle. Arthritis Rheum 30:793-800.
56. Vincent, A., N. Willcox, M. Hill, J. Curnow, C. MacLennan, and D. Beeson. 1998. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 164:157-168.
57. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54 Pt 1:1-13.
58. Hultman, P., S. Enestrom, K.M. Pollard, and E.M. Tan. 1989. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin Exp Immunol 78:470-477.
59. Reuter, R., G. Tessars, H.W. Vohr, E. Gleichmann, and R. Luhrmann. 1989. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci USA 86:237-241.
60. Hultman, P., L. J. Bell, S. Enestrom, and K.M. Pollard. 1992. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 65:98-109.
61. Pollard, K. M., E. K. Chan, R. L. Rubin, and E.M. Tan. 1987. Monoclonal autoantibodies to nuclear antigens from murine graft-versus-host disease. Clin Immunol Immunopathol 44:31-40.
62. Gelpi, C., J. L. Rodriguez-Sanchez, M.A. Martinez, J. Craft, and J. A. Hardin. 1988. Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins. J Immunol 140:4160-4166.
63. Kofler, R., F. J. Dixon, and A. N. Theofilopoulos. 1989. Genetic basis for autoantibody-production in murine models of systemic autoimmunity. Contrib Microbiol Immunol 11:206-230.
64. Burlingame, R.W., R.L. Rubin, R. S. Balderas, and A. N. Theofilopoulos. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91:1687-1696.
65. Watanabe-Fukunaga, R., C. I. Brannan, N.G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
66. Kono, D. H., and A. N. Theofilopoulos. 2000. Genetics of systemic autoimmunity in mouse models of lupus. Int Rev Immunol 19:367-387.
67. Pollard, K. M., D.L. Pearson, P. Hultman, T. N. Deane, U. Lindh, and D.H. Kono. 2001. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. Environ Health Perspect 109:27-33.
68. Yoshida, H., M. Satoh, K.M. Behney, C.G. Lee, H.B. Richards, V.M. Shaheen, J.Q. Yang, R. R. Singh, and W.H. Reeves. 2002. Effect of an exogenous trigger on the pathogenesis of lupus in (NZBXNZW) F1 mice. Arthritis Rheum 46:2235-2244.
69. Kono, D. H., D. Balomenos, D.L. Pearson, M.S. Park, B. Hildebrandt, P. Hultman, and K.M. Pollard. 1998. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol 161:234-240.
70. Balomenos, D., R. Rumold, and A. N. Theofilopoulos. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 101:364-371.
71. Seery, J. P., J.M. Carroll, V. Cattell, and F.M. Watt. 1997. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med 186:1451-1459.
72. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferoninducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15:435-443.
73. Mitchell, D.A., M.C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H.T. Cook, M. Botto, and M.J. Walport. 2002. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 168:2538-2543.
74. Scott, R. S., E. J. McMahon, S.M. Pop, E. A. Reap, R. Caricchio, P. L. Cohen, H.S. Earp, and G.K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207-211.
75. Carter, L. B., J. L. Procter, J.K. Dale, S. E. Straus, and C. C. Cantilena. 2000. Description of serologic features in autoimmune lymphoproliferative syndrome. Transfusion 40:943-948.
76. Napirei, M., H. Karsunky, B. Zevnik, H. Stephan, H.G. Mannherz, and T. Moroy. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177-181.
77. Yasutomo, K., T. Horiuchi, S. Kagami, H. Tsukamoto, C. Hashimura, M. Urushihara, and Y. Kuroda. 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28:313-314.
78. Simmonds, M. J., J.M. Heward, M.A. Kelly, A. Allahabadia, H. Foxall, C. Gordon, J. A. Franklyn, and S. C. Gough. 2002. A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al. Arthritis Rheum 46:3109-3110.
79. Goodnow, C. C., R. Glynne, S. Akkaraju, J. Rayner, D. Mack, J. I. Healy, S. Chaudhry, L. Miosge, L. Wilson, P. Papathanasiou, and A. Loy. 2001. Autoimmunity, self-tolerance and immune homeostasis: from whole animal phenotypes to molecular pathways. Adv Exp Med Biol 490:33-40.
80. Kono, D. H., M.S. Park, A. Szydlik, K.M. Haraldsson, J.D. Kuan, D.L. Pearson, P. Hultman, and K.M. Pollard. 2001. Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J Immunol 167:2396-2403.